Aurobindo Pharma Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
80,274
120,272
135,341
146,732
162,094
Cost of Goods Sold (COGS) incl. D&A
54,717
80,123
87,995
92,950
101,705
Gross Income
25,557
40,148
47,346
53,783
60,390
SG&A Expense
7,239
16,711
20,829
24,909
29,404
EBIT
17,627
21,779
-
-
30,231
Unusual Expense
-
-
-
-
-
Non Operating Income/Expense
762
1,342
4,068
3,024
2,805
Interest Expense
3,102
1,599
2,567
667
776
Pretax Income
15,325
21,679
27,443
30,558
32,380
Income Tax
3,635
5,966
7,207
7,597
8,183
Equity in Affiliates
-
-
-
50
31
Consolidated Net Income
11,691
15,713
20,236
23,012
24,229
Net Income
11,729
15,758
20,251
23,017
24,232
Net Income After Extraordinaries
11,729
15,758
20,251
23,017
24,232
Net Income Available to Common
11,729
15,758
20,251
23,017
24,232
EPS (Basic)
20.14
27.03
34.67
39.33
41.36
Basic Shares Outstanding
582
583
584
585
586
EPS (Diluted)
20.11
27.00
34.66
39.33
41.36
Diluted Shares Outstanding
583
584
584
585
586
EBITDA
20,753
25,106
29,748
32,316
35,811
Other Operating Expense
690
1,658
692
834
755
Non-Operating Interest Income
38
156
104
162
120
Minority Interest Expense
38
45
15
5
3
Equity in Affiliates (Pretax)
-
-
15
-
-
About Aurobindo Pharma
View Profile
